David I. Bernstein

52.7k citations

696 papers · 32.5k indexed · 10 hit papers · h-index 93

Impact in

Immunology and Allergy top 0.01%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 0.02%
- Dermatology and Skin Diseases

Papers in

Immunology and Allergy 171
- Allergic Rhinitis and Sensitization 159
Dermatology 122
- Dermatology and Skin Diseases 63
- Contact Dermatitis and Allergies 57

Co-authors: Jonathan A. Bernstein Lawrence R. Stanberry Susan L. Rosenthal Jessica A. Kahn David M. Lang Richard A. Nicklas Gregg N. Milligan Gary M. Liss
Journals: Journal of Allergy and Clinical Immunology (126 papers)The Journal of Infectious Diseases (51 papers)Annals of Allergy Asthma & Immunology (49 papers)Vaccine (35 papers)The Journal of Allergy and Clinical Immunology In Practice (26 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

David I. Bernstein

678 papers receiving 31.1k citations

Hit Papers

10 papers align trajectories log scale

Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype 2024 · 47 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 New England Journal of Medicine
2024 The Journal of Infectious Diseases
2014 Journal of Allergy and Clinical Immunology
2013 New England Journal of Medicine
2012 New England Journal of Medicine
2010 Journal of Allergy and Clinical Immunology
2008 Journal of Allergy and Clinical Immunology
2006 New England Journal of Medicine
2002 New England Journal of Medicine
1998 New England Journal of Medicine

Peers

Countries citing papers authored by David I. Bernstein

Since Specialization

Citations

This map shows the geographic impact of David I. Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Bernstein more than expected).

Fields of papers citing papers by David I. Bernstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Bernstein. The network helps show where David I. Bernstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David I. Bernstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David I. Bernstein Line = papers co-authored together David I. Bernstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacokinetics of Epinephrine Nasal Spray under Various Conditions Journal of Allergy and Clinical Immunology ·David M. Fleischer, John Oppenheimer, David I. Bernstein, Thomas B. Casale, Jonathan M. Spergel, Richard Lowenthal, nazihark	2025	0
2	Upper respiratory tract infections have minimal impact on neffy’s pharmacokinetics or pharmacodynamics The Journal of Allergy and Clinical Immunology In Practice ·John Oppenheimer, Joel Birman, Carlos A. Camargo, 赵淳, David I. Bernstein, Kunitake Hayashi, nazihark	2024	9
3	Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype New England Journal of Medicine ·David J. Jackson, Michael E. Wechsler, Daniel J. Jackson, David I. Bernstein, Stephanie Korn, Paul Pfeffer, Ruchong Chen, Junpei Saito, R. W. MILLS, A. Taka-hisa, Loretta Jacques, Victor Emmanuel Avelino Gomes Bahia, Stein Schalkwijk, Douglas G. Smith, Peter Howarth, Ian Pavord Hit paper breakdown →	2024	47
4	Anaphylaxis in Clinical Trials of Sublingual Immunotherapy Tablets The Journal of Allergy and Clinical Immunology In Practice ·Hendrik Nolte, Moisés A. Calderón, David I. Bernstein, Graham Roberts, Merve Boyacı, 恵良田知樹, Veronica Hulstrøm	2023	10
5	Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV Antiviral Research ·David I. Bernstein, Nancy Sawtell, ایرج فیضی, 蔡晨阳, Christian Gege, Gerald Kleymann	2023	10
6	Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era The Journal of Applied Laboratory Medicine ·David I. Bernstein, Asunción Mejías, Barbara Rath, Christopher W. Woods, Kudsy Mahally	2022	12
7	Efficacy of House Dust Mite Sublingual Immunotherapy-Tablet in Tree and/or Grass Poly-Sensitized Subjects Journal of Allergy and Clinical Immunology ·David I. Bernstein, Hendrik Nolte, Harold S. Nelson, Dorte Rehm	2019	2
8	The Pediatric Asthma Risk Score (PARS) Predicts Atopic and Non-atopic Asthma Better than the Asthma Predictive Index Journal of Allergy and Clinical Immunology ·Eric Schauberger, Jocelyn Biagini Myers, Hua He, Lisa J. Martin, John Kroner, Patrick Ryan, David I. Bernstein, James E. Lockey, Grace K. LeMasters, Syed Hasan Arshad, Ramesh Kurukulaaratchy, Gurjit K. Khurana Hershey	2019	2
9	Identification of Two Early Life Eczema and Non-Eczema Phenotypes With High Risk For Asthma Development Journal of Allergy and Clinical Immunology ·Elisabet Johansson, Jocelyn M. Biagini Myers, Lisa J. Martin, Hua He, Patrick Ryan, Grace K. LeMasters, David I. Bernstein, James E. Lockey, Gurjit K. Khurana Hershey	2019	1
10	Identification of two early life eczema and non‐eczema phenotypes with high risk for asthma development Clinical & Experimental Allergy ·Elisabet Johansson, Jocelyn M. Biagini Myers, Lisa J. Martin, Hua He, Patrick Ryan, Grace K. LeMasters, David I. Bernstein, James E. Lockey, Gurjit K. Khurana Hershey	2019	10
11	Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period Journal of Allergy and Clinical Immunology ·Petra Zieglmayer, Hendrik Nolte, Harold S. Nelson, David I. Bernstein, Amarjot Kaur, Ziliang Li, René Zieglmayer, René Schmutz, Patrick Lemell, Friedrich Horak	2016	1
12	Sublingual grass and ragweed immunotherapy: Clinical considerations—a PRACTALL consensus report Journal of Allergy and Clinical Immunology ·James T. Li, David I. Bernstein, Moisés A. Calderón, Thomas B. Casale, Linda Cox, Giovanni Passalacqua, Oliver Pfaar, Nikolaos G. Papadopoulos	2015	31
13	N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma Journal of Occupational and Environmental Medicine ·Berran Yücesoy, Grace E. Kissling, Victor J. Johnson, Zana L. Lummus, Denyse Gautrin, André Cartier, Louis‐Philippe Boulet, J. Sastre, Santiago Quirce, Susan M. Tarlo, María Jesús Cruz, Xavier Muñoz, Michael I. Luster, David I. Bernstein	2015	8
14	Interferon-γ Promoter Is Hypermethylated in Blood DNA from Workers with Confirmed Diisocyanate Asthma Toxicological Sciences ·Bin Ouyang, David I. Bernstein, Zana L. Lummus, Jun Ying, Louis‐Philippe Boulet, André Cartier, Denyse Gautrin, Shuk‐Mei Ho	2013	30
15	Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE Journal of Allergy and Clinical Immunology ·Linda Cox, Thomas B. Casale, Anjuli Nayak, David I. Bernstein, Peter S. Creticos, Laurence Ambroisine, Michel Mélac, Robert K. Zeldin	2012	109
16	Genetic Variants in Antioxidant Genes Are Associated With Diisocyanate-Induced Asthma Toxicological Sciences ·Berran Yücesoy, Victor J. Johnson, Zana L. Lummus, Grace E. Kissling, Kara Fluharty, Denyse Gautrin, Jean‐Luc Malo, André Cartier, Louis‐Philippe Boulet, J. Sastre, Santiago Quirce, Dori R. Germolec, Susan M. Tarlo, María Jesús Cruz, Xavier Muñoz, Michael I. Luster, David I. Bernstein	2012	38
17	CTNNA3 (α-Catenin) Gene Variants Are Associated With Diisocyanate Asthma: A Replication Study in a Caucasian Worker Population Toxicological Sciences ·David I. Bernstein, Michael L. Kashon, Zana L. Lummus, Victor J. Johnson, Kara Fluharty, Denyse Gautrin, Jean‐Luc Malo, André Cartier, Louis‐Philippe Boulet, J. Sastre, Santiago Quirce, Dori R. Germolec, Susan M. Tarlo, María Jesús Cruz, Xavier Muñoz, Michael I. Luster, Berran Yücesoy	2012	34
18	Sexually transmitted diseases : vaccines, prevention and control Academic Press eBooks ·Lawrence R. Stanberry, David I. Bernstein	2000	26
19	Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria Journal of Allergy and Clinical Immunology ·John T. Grant, David I. Bernstein, C.E. Buckley, Tony Chu, Roger W. Fox, Ross E. Rocklin, William F. Schoenwetter, S L Spector, Chester T. Stafford, Renato Henrique Ferreira Branco, Kathleen Hague	1988	41
20	Occupational asthma caused by himic anhydride. Scandinavian Journal of Work Environment & Health ·N Morimura, David I. Bernstein, Kevin J. O’Leary, Joan S. Gallagher, Lionel D’Souza, Jonathan A. Bernstein	1987	13

About David I. Bernstein

David I. Bernstein is a scholar working on Immunology and Allergy, Dermatology, Epidemiology, Physiology and Chemical Health and Safety, having authored 696 papers that have together received 32.5k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (168 papers), Allergic Rhinitis and Sensitization (159 papers), Herpesvirus Infections and Treatments (147 papers), Cytomegalovirus and herpesvirus research (79 papers), Occupational exposure and asthma (74 papers), Viral gastroenteritis research and epidemiology (66 papers), Dermatology and Skin Diseases (63 papers) and Contact Dermatitis and Allergies (57 papers). The work is most often cited by research in Immunology and Allergy (7.5k citations), Dermatology (4.7k citations), Infectious Diseases (7.1k citations), Epidemiology (12.0k citations) and Physiology (6.9k citations). David I. Bernstein has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jonathan A. Bernstein, Lawrence R. Stanberry, Susan L. Rosenthal, Jessica A. Kahn, David M. Lang, Richard A. Nicklas, Gregg N. Milligan, Gary M. Liss, Robert B. Belshe and David A. Khan. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Infectious Diseases, Annals of Allergy Asthma & Immunology, Vaccine and The Journal of Allergy and Clinical Immunology In Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact